Nitecapone reduces development and symptoms of neuropathic pain after spinal nerve ligation in rats

European Journal of Pain

Volumn 15, Issue 7, 2011, Pages 732-740

  Kambur, Oleg ^a,b   Männistö, Pekka T ^a   Pusa, Anne M ^a   Käenmäki, Mikko ^a   Kalso, Eija A ^b,c   Kontinen, Vesa K ^b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Allodynia; COMT; Neuropathic pain; Nitecapone; Rat; Spinal nerve ligation

Indexed keywords

ACETONE; NITECAPONE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD EXPOSURE; COMPARATIVE STUDY; CONTROLLED STUDY; MALE; MECHANICAL STIMULATION; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SPINAL NERVE;

ANIMALS; CATECHOL O-METHYLTRANSFERASE; CATECHOLS; DISEASE MODELS, ANIMAL; HYPERALGESIA; MALE; NEURALGIA; PAIN THRESHOLD; PENTANONES; PHYSICAL STIMULATION; RATS; RATS, WISTAR; SPINAL NERVES;

EID: 79960902919     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2010.12.001     Document Type: Article

References (78)

1. P.A. Aho, and I.B. Lindén Role of gastric mucosal eicosanoid production in the cytoprotection induced by nitecapone Scan J Gastroenterol 27 1992 134 138
2. O.B. Ansah, H. Leite-Almeida, H. Wei, and A. Pertovaara Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat Exp Neurol 205 2007 536 546 (Pubitemid 46755776)
3. P. Armero, C. Muriel, J. Santos, F.J. Sanchez-Montero, R.E. Rodriguez, and R. Gonzalez-Sarmiento COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population Eur J Pain 9 2005 229 232 (Pubitemid 40615702)
4. A. Berthele, S. Platzer, B. Jochim, H. Boecker, A. Buettner, and B. Conrad COMT Val108/158Met genotype affects the mu-opioid receptor system in the human brain: evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression Neuroimage 28 2005 185 193 (Pubitemid 41393899)
5. R. Bäckström, E. Honkanen, A. Pippuri, P. Kairisalo, J. Pystynen, and K. Heinola Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors J Med Chem 32 1989 841 846 (Pubitemid 19100197)
6. B. Boudikova, C. Szumlanski, B. Maidak, and R. Weinshilboum Human liver catechol-O-methyltransferase pharmacogenetics Clin Pharmacol Ther 48 1990 381 389 (Pubitemid 20362271)
7. C. Brefel-Courbon, P. Payoux, C. Thalamas, F. Ory, I. Quelven, and F. Chollet Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study Mov Disord 20 2005 1557 1563
8. D. Bridges, S.W. Thompson, and A.S. Rice Mechanisms of neuropathic pain Br J Anaesth 87 2001 12 26 (Pubitemid 32631672)
9. Y. Choi, Y.W. Yoon, H.S. Na, S.H. Kim, and J.M. Chung Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain Pain 59 1994 369 376
10. H. Cohen, L. Neumann, Y. Glazer, R.P. Ebstein, and D. Buskila The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia Clin Exp Rheumatol 27 2009 S51 56
11. M. Costigan, K. Befort, L. Karchewski, R.S. Griffin, D. D'Urso, and A. Allchorne Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury BMC Neurosci 3 2002 16
12. M. Costigan, J. Scholz, and C.J. Woolf Neuropathic pain: a maladaptive response of the nervous system to damage Annu Rev Neurosci 32 2009 1 32
13. M.P. Davis What is new in neuropathic pain? Support Care Cancer 15 2007 363 372 (Pubitemid 46697011)
14. L. Diatchenko, A.G. Nackley, G.D. Slade, K. Bhalang, I. Belfer, and M.B. Max Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli Pain 125 2006 216 224 (Pubitemid 44708465)
15. L. Diatchenko, G.D. Slade, A.G. Nackley, K. Bhalang, A. Sigurdsson, and I. Belfer Genetic basis for individual variations in pain perception and the development of a chronic pain condition Hum Mol Genet 14 2005 135 143 (Pubitemid 40123469)
16. R. Djaldetti, A. Shifrin, Z. Rogowski, E. Sprecher, E. Melamed, and D. Yarnitsky Quantitative measurement of pain sensation in patients with Parkinson disease Neurology 62 2004 2171 2175 (Pubitemid 38787770)
17. R.H. Dworkin, A.B. O'Connor, M. Backonja, J.T. Farrar, N.B. Finnerup, and T.S. Jensen Pharmacologic management of neuropathic pain: evidence-based recommendations Pain 132 2007 237 251 (Pubitemid 350051570)
18. J.T. Farrar, J.P. Young Jr., L. LaMoreaux, J.L. Werth, and R.M. Poole Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale Pain 94 2001 149 158 (Pubitemid 33016608)
19. P.H. Finan, A.J. Zautra, M.C. Davis, K. Lemery-Chalfant, J. Covault, and H. Tennen Genetic influences on the dynamics of pain and affect in fibromyalgia Health Psychol 29 2010 134 142
20. N.B. Finnerup, M. Otto, H.J. McQuay, T.S. Jensen, and S.H. Sindrup Algorithm for neuropathic pain treatment: an evidence based proposal Pain 118 2005 289 305 (Pubitemid 41752987)
21. X. Gao, H.K. Kim, J.M. Chung, and K. Chung Enhancement of NMDA receptor phosphorylation of the spinal dorsal horn and nucleus gracilis neurons in neuropathic rats Pain 116 2005 62 72 (Pubitemid 40828501)
22. N. Hagelberg, S.K. Jääskeläinen, I.K. Martikainen, H. Mansikka, H. Forssell, and H. Scheinin Striatal dopamine D2 receptors in modulation of pain in humans: a review Eur J Pharmacol 500 2004 187 192 (Pubitemid 39304007)
23. N. Hagelberg, I.K. Martikainen, H. Mansikka, S. Hinkka, K. Nagren, and J. Hietala Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity Pain 99 2002 273 279 (Pubitemid 35247550)
24. M. Huotari, R. Gainetdinov, and P.T. Männistö Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats Pharmacol Toxicol 85 1999 233 238
25. M. Huotari, J.A. Gogos, M. Karayiorgou, O. Koponen, M. Forsberg, and A. Raasmaja Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice Eur J Neurosci 15 2002 246 256 (Pubitemid 35471947)
26. T. Hökfelt, X. Zhang, and Z. Wiesenfeld-Hallin Messenger plasticity in primary sensory neurons following axotomy and its functional implications Trends Neurosci 17 1994 22 30 (Pubitemid 24024322)
27. L.M. Jacobsen, G.S. Eriksen, L.M. Pedersen, and J. Gjerstad Catechol-O-methyltransferase (COMT) inhibition reduces spinal nociceptive activity Neurosci Lett 473 2010 212 215
28. T.S. Jensen, and N.B. Finnerup Management of neuropathic pain Curr Opin Support Palliat Care 1 2007 126 131
29. S.K. Joshi, G. Hernandez, J.P. Mikusa, C.Z. Zhu, C. Zhong, and A. Salyers Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity Neuroscience 143 2006 587 596 (Pubitemid 44716595)
30. O. Kambur, R. Talka, O.B. Ansah, V.K. Kontinen, A. Pertovaara, and E.A. Kalso Catechol-O-methyltransferase inhibitors sensitize mice to pain Br J Pharmacol 161 2010 1553 1565
31. O. Kambur, P.T. Männistö, K. Viljakka, I. Reenila, K. Lemberg, and V.K. Kontinen Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice Basic Clin Pharmacol Toxicol 103 2008 367 373
32. H.K. Kim, J.H. Kim, X. Gao, J.L. Zhou, I. Lee, and K. Chung Analgesic effect of vitamin E is mediated by reducing central sensitization in neuropathic pain Pain 122 2006 53 62
33. H.K. Kim, S.K. Park, J.L. Zhou, G. Taglialatela, K. Chung, and R.E. Coggeshall Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain Pain 111 2004 116 124 (Pubitemid 39141013)
34. S.H. Kim, and J.M. Chung An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat Pain 50 1992 355 363
35. M. Käenmäki, A. Tammimäki, T. Myöhänen, K. Pakarinen, C. Amberg, and M. Karayiorgou Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice J Neurochem 114 2010 1745 1755
36. M.A. Lal, A. Korner, Y. Matsuo, S. Zelenin, S.X. Cheng, and G. Jaremko Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats Diabetes 49 2000 1381 1389 (Pubitemid 30624240)
37. D.H. Lee, K. Chung, and J.M. Chung Strain differences in adrenergic sensitivity of neuropathic pain behaviors in an experimental rat model Neuroreport 8 1997 3453 3456 (Pubitemid 27497463)
38. L. Leventhal, V. Smith, G. Hornby, T.H. Andree, M.R. Brandt, and K.E. Rogers Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain J Pharmacol Exp Ther 320 2007 1178 1185 (Pubitemid 46294041)
39. Y.H. Li, T. Wirth, M. Huotari, K. Laitinen, E. MacDonald, and P.T. Männistö No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats Eur J Pharmacol 356 1998 127 137 (Pubitemid 28439125)
40. J.A. Lovell, S.L. Stuesse, W.L. Cruce, and T. Crisp Strain differences in neuropathic hyperalgesia Pharmacol Biochem Behav 65 2000 141 144 (Pubitemid 30018006)
41. J. Lötsch, N. von Hentig, R. Freynhagen, N. Griessinger, M. Zimmermann, and A. Doehring Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers Pharmacogenet Genom 19 2009 429 436
42. H. Mansikka, E. Erbs, E. Borrelli, and A. Pertovaara Influence of the dopamine D2 receptor knockout on pain-related behavior in the mouse Brain Res 1052 2005 82 87 (Pubitemid 41116289)
43. M.B. Max, T. Wu, S.J. Atlas, R.R. Edwards, J.A. Haythornthwaite, and A.F. Bollettino A clinical genetic method to identify mechanisms by which pain causes depression and anxiety Mol Pain 2 2006 14
44. P.T. Männistö, and S. Kaakkola Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors Pharmacol Rev 51 1999 593 628
45. P.T. Männistö, S. Kaakkola, E. Nissinen, I.B. Lindén, and P. Pohto Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase Life Sci 43 1988 1465 1471
46. L. Marcocci, J.J. Maguire, and L. Packer Nitecapone: a nitric oxide radical scavenger Biochem Mol Biol Int 34 1994 531 541 (Pubitemid 24325417)
47. L. Marcocci, Y.J. Suzuki, M. Tsuchiya, and L. Packer Antioxidant activity of nitecapone and its analog OR-1246: effect of structural modification on antioxidant action Methods Enzymol 234 1994 526 541
48. A.G. Nackley, K.S. Tan, K. Fecho, P. Flood, L. Diatchenko, and W. Maixner Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors Pain 128 2007 199 208 (Pubitemid 46367417)
49. A. Nikoshkov, K. Drakenberg, X. Wang, M.C. Horvath, E. Keller, and Y.L. Hurd Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression Proc Natl Acad Sci USA 105 2008 786 791 (Pubitemid 351171786)
50. E. Nissinen, I.B. Lindén, and P. Pohto Antioxidant properties of nitecapone are potentiated by glutathione Biochem Mol Biol Int 35 1995 387 395 (Pubitemid 26177809)
51. E. Nissinen, I.B. Lindén, E. Schultz, S. Kaakkola, P.T. Männistö, and P. Pohto Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat Eur J Pharmacol 153 1988 263 269
52. E. Nissinen, and P. Männistö Determination of catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection Anal Biochem 137 1984 69 73 (Pubitemid 14165428)
53. A. Pertovaara, I.K. Martikainen, N. Hagelberg, H. Mansikka, K. Nagren, and J. Hietala Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain Eur J Neurosci 20 2004 1587 1592 (Pubitemid 39274041)
54. A. Pertovaara, H. Wei, J. Kalmari, and M. Ruotsalainen Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in the rat: modulation by nitecapone, a comt inhibitor with antioxidant properties Exp Neurol 167 2001 425 434 (Pubitemid 32150900)
55. T.T. Rakvg, P. Klepstad, C. Baar, T.M. Kvam, O. Dale, and S. Kaasa The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients Pain 116 2005 73 78 (Pubitemid 40828502)
56. T.T. Rakvg, J.R. Ross, H. Sato, F. Skorpen, S. Kaasa, and P. Klepstad Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain Mol Pain 4 2008 64
57. I. Reenilä, P. Tuomainen, and P.T. Männistö Improved assay of reaction products to quantitate catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection J Chromatogr B Biomed Appl 663 1995 137 142
58. D. Salvemini, Z.Q. Wang, J.L. Zweier, A. Samouilov, H. Macarthur, and T.P. Misko A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats Science 286 1999 304 306 (Pubitemid 29484695)
59. G.D. Schott Pain in Parkinson's disease Pain 22 1985 407 411 (Pubitemid 15014129)
60. D.J. Scott, M.M. Heitzeg, R.A. Koeppe, C.S. Stohler, and J.K. Zubieta Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity J Neurosci 26 2006 10789 10795
61. S.H. Sindrup, and T.S. Jensen Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action Pain 83 1999 389 400
62. G.D. Slade, L. Diatchenko, K. Bhalang, A. Sigurdsson, R.B. Fillingim, and I. Belfer Influence of psychological factors on risk of temporomandibular disorders J Dent Res 86 2007 1120 1125
63. Y.J. Suzuki, M. Tsuchiya, A. Safadi, V.E. Kagan, and L. Packer Antioxidant properties of nitecapone (OR-462) Free Radic Biol Med 13 1992 517 525
64. M. Tal A novel antioxidant alleviates heat hyperalgesia in rats with an experimental painful peripheral neuropathy Neuroreport 7 1996 1382 1384 (Pubitemid 26280996)
65. R.S. Taylor Epidemiology of refractory neuropathic pain Pain Pract 6 2006 22 26 (Pubitemid 43732685)
66. J. Tenorio-Laranga, P.T. Männistö, M. Karayiorgou, J.A. Gogos, and J.A. Garcia-Horsman Sex-dependent compensated oxidative stress in the mouse liver upon deletion of catechol O-methyltransferase Biochem Pharmacol 77 2009 1541 1552
67. N. Torrance, B.H. Smith, M.I. Bennett, and A.J. Lee The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey J Pain 7 2006 281 289
68. E.M. Tunbridge, D.M. Bannerman, T. Sharp, and P.J. Harrison Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex J Neurosci 24 2004 5331 5335 (Pubitemid 38747674)
69. M.O. Urban, K. Ren, K.T. Park, B. Campbell, N. Anker, and B. Stearns Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action J Pharmacol Exp Ther 313 2005 1209 1216 (Pubitemid 40727024)
70. G. Vargas-Alarcon, J.M. Fragoso, D. Cruz-Robles, A. Vargas, J.I. Lao-Villadoniga, and F. Garcia-Fructuoso Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia Arthritis Res Ther 9 2007 R110
71. Z.Q. Wang, F. Porreca, S. Cuzzocrea, K. Galen, R. Lightfoot, and E. Masini A newly identified role for superoxide in inflammatory pain J Pharmacol Exp Ther 309 2004 869 878 (Pubitemid 38669673)
72. R.M. Weinshilboum, and F.A. Raymond Inheritance of low erythrocyte catechol-O-methyltransferase activity in man Am J Hum Genet 29 1977 125 135 (Pubitemid 8070429)
73. W. Wisden, A.L. Gundlach, E.A. Barnard, P.H. Seeburg, and S.P. Hunt Distribution of GABA-A receptor subunit mRNAs in rat lumbar spinal cord Brain Res Mol Brain Res 10 1991 179 183
74. C.J. Woolf, and R.J. Mannion Neuropathic pain: aetiology, symptoms, mechanisms, and management Lancet 353 1999 1959 1964
75. L. Yavich, M.M. Forsberg, M. Karayiorgou, J.A. Gogos, and P.T. Männistö Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum J Neurosci 27 2007 10196 10209
76. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110 (Pubitemid 13058546)
77. M. Zimmermann Pathobiology of neuropathic pain Eur J Pharmacol 429 2001 23 37 (Pubitemid 33043979)
78. J.K. Zubieta, M.M. Heitzeg, Y.R. Smith, J.A. Bueller, K. Xu, and Y. Xu Comt val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor Science 299 2003 1240 1243 (Pubitemid 36237467)